NDC 85237-1841-01 - Midol Complete
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1841
- Requested NDC
- 85237-1841-01
- Package NDCs from labels
- 85237-1841-1, 85237-1841-2, 85237-1841-3, 85237-1841-4, 85237-1841-5, 85237-1841-01
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-07-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Midol Complete - Select Consumer Group | Select Consumer Group | 2026-07-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1841-1 | Midol Complete | 1 in 1 BLISTER PACK | TABLET | 1 | 2 | |
| 85237-1841-1 | Midol Complete | 2 in 1 POUCH | TABLET | 2 | 2 | |
| 85237-1841-2 | Midol Complete | 2 in 1 BLISTER PACK | TABLET | 2 | 2 | |
| 85237-1841-2 | Midol Complete | 2 in 1 POUCH | TABLET | 2 | 2 | |
| 85237-1841-3 | Midol Complete | 2 in 1 POUCH | TABLET | 2 | 2 | |
| 85237-1841-3 | Midol Complete | 20 in 1 BOX, UNIT-DOSE | TABLET | 20 | 2 | |
| 85237-1841-4 | Midol Complete | 2 in 1 POUCH | TABLET | 2 | 2 | |
| 85237-1841-4 | Midol Complete | 25 in 1 BOX, UNIT-DOSE | TABLET | 25 | 2 | |
| 85237-1841-5 | Midol Complete | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 2 | |
| 85237-1841-5 | Midol Complete | 2 in 1 POUCH | TABLET | 2 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 7f5e6872-4d26-410e-8afe-16a016f9a399 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 1124ba7d-a328-409b-8c88-e74bb3e501f5 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 9c407dc7-fcde-4660-9a06-57bd8a6b867d | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | f07e8bb2-30ae-4337-ad60-84f55f2ff354 | 2019-10-08 | Warnings | 15FIX9V2JP |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Proficient Rx LP | df97ea5a-51df-453b-b1b4-edc74c718ee7 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| butalbital, acetaminophen and caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Lannett Company, Inc. | c1107153-494b-4068-8500-96bc241187a5 | 2019-06-01 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E 362O9ITL9D |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Westminster Pharmaceuticals, LLC | 1c0511d0-fe63-45c6-8da2-6ceeb56edb17 | 2019-03-01 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Aphena Pharma Solutions - Tennessee, LLC | 89134c3e-ec5b-4a57-952a-98d6c6cff7c2 | 2019-02-26 | Warnings | 362O9ITL9D |
| CounterAct PM | ACETAMINOPHEN AND DIPHENHYDRAMINE | Melaleuca, Inc. | 7f9a0062-0e86-1deb-e053-2a91aa0a9188 | 2019-01-18 | Warnings | 362O9ITL9D |
| Acetaminophen 500mg ES | ACETAMINOPHEN 500MG | Allegiant Health | 91acc132-01b6-467b-9af5-70f4dc93e087 | 2019-01-08 | Warnings | 362O9ITL9D |
| Stay Awake | CAFFEINE | Allegiant Health | 959b50a1-3037-4f94-8bc5-651501815092 | 2019-01-08 | Warnings | 3G6A5W338E |
| Acetaminophen 325mg RS | ACETAMINOPHEN 325MG | Allegiant Health | 61c6d281-e59b-4277-bbce-f71c12c2a56d | 2019-01-07 | Warnings | 362O9ITL9D |
| Cold Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Allegiant Health | 9a4c0c43-a71a-4e22-a3d5-9eb9622689a2 | 2019-01-02 | Warnings | 362O9ITL9D |
| Pressure Pain Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Chain Drug Marketing Association | 1e54ecb3-c3c3-477a-8725-23f24e77a44b | 2018-12-31 | Warnings | 362O9ITL9D |
| Pain Relief PM Extra Strength | ACETAMINOPHEN 500 MG AND DIPHENHYDRAMINE HCL 25 MG | Allegiant Health | 423a8445-964c-4cdb-889a-f391ca5253e7 | 2018-12-31 | Warnings | 362O9ITL9D |
| Cold Multi-Symptom Night-time | ACETAMINOPHEN,CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR AND PHENYLEPHRINE HCI | Allegiant Health | 3f020cf2-6011-4216-9b39-0b3dc5f0749c | 2018-12-26 | Warnings | 362O9ITL9D |
| Sinus Headache PEMaximum Strength Non-Drowsy Maximum Strength Non-Drowsy | ACETAMINOPHEN AND PHENYLEPHRINE HCL | Allegiant Health | b04b96e0-d99b-48d1-b8b8-e2fdd8dd3f5f | 2018-12-21 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | TIME CAP LABORATORIES, INC | 2569383a-4a05-4ddb-852e-b37e487ffcde | 2018-12-17 | Warnings | 362O9ITL9D |
| Alert | CAFFEINE | Time Cap Labs, Inc | d221f66d-06bb-44e8-a01b-f5919f5c52d2 | 2018-12-17 | Warnings | 3G6A5W338E |
| Comfort-Time | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Time Cap Labs, Inc | e94a26a2-36e5-4e1e-aea1-24e035c98043 | 2018-12-14 | Warnings | 1597298 3G6A5W338E R35D29L3ZA 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.